about us
our story
Together with our patients, we strive to extend survival in some of the most aggressive forms of cancer by developing and commercializing our innovative therapy. Learn more about our story, from our founding in Haifa, Israel in 2000 to having grown into a global oncology company today.
our leadership
Meet our leaders, who have extensive experience across oncology, biotechnology and medical device industries.
We join together with patients, caregivers and advocacy partners in their dedication to redefine living with cancer.
Corporate social responsibility is important to us, and patients remain at the heart of the work we do every day.
external funding
Novocure is dedicated to supporting independent organizations with shared goals related to advancing medical care and improving patient outcomes.
our pipeline
our pipeline
Tumor Treating Fields have shown a consistent anti-mitotic effect in our preclinical and clinical research spanning more than two decades.
The science of Tumor Treating Fields extends beyond glioblastoma and mesothelioma. Novocure has ongoing or completed clinical trials investigating our therapy in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer and ovarian cancer.
news and media
news and media
View our press kit, read stories about our company and reach out if you’d like an interview or more information about Novocure.
press releases
Stay on top of Novocure news by viewing our latest announcements.
learn more
Learn more about our company and our mission through stories about patients, our colleagues, our collaborators and our culture.